side effects

Ozempic and Wegovy Linked to Severe Vision Loss in New Study

The popular diabetes and weight loss medications Ozempic and Wegovy, both containing the active ingredient semaglutide, have been hailed as revolutionary treatments in recent years. However, a new semaglutide study published this month in the medical journal JAMA Ophthalmology has uncovered a troubling connection between these popular drugs and a debilitating eye condition called nonarteritic […]

Ozempic and Wegovy Linked to Severe Vision Loss in New Study Read More »

Study Finds Side Effects of GLP-1 Drugs Could Cause Bone Density Loss

A troubling new study has uncovered another potential side effect of Ozempic, Wegovy, Mounjaro, and other popular glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. According to researchers, these in-demand treatments may be linked to a significant reduction in bone mineral density (BMD), potentially putting users at risk of osteoporosis and fractures. As the medical community

Study Finds Side Effects of GLP-1 Drugs Could Cause Bone Density Loss Read More »

New Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects of Wegovy

Wegovy, a higher-dose version of the widely used diabetes drug Ozempic, has gained significant popularity in recent years as a weight-loss aid. However, a growing number of individuals across the United States are now pursuing legal action against the manufacturer, Novo Nordisk, alleging that the company failed to adequately warn about the potential risks associated

New Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects of Wegovy Read More »

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers

In a notable development in the ongoing valsartan litigation, lawyers are nearing a settlement agreement for those who sued Hetero, a manufacturer of the generic blood pressure medication that was tainted with carcinogenic impurities. This settlement, overseen by U.S. District Court Judge Renée M. Bumb in New Jersey, aims to provide relief to a subset

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers Read More »

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims

One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood pressure medication. The U.S. District Judge presiding over the valsartan lawsuits has been informed that a preliminary settlement agreement has been reached with Hetero Drugs,

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More »

Wegovy Gastroparesis Lawsuits: Patients Seek Compensation for Stomach Paralysis Injuries

Despite the growing popularity of Novo Nordisk’s semaglutide-based Wegovy as a solution for weight loss, an alarming number of Wegovy users have reported severe gastrointestinal complications, including a debilitating condition known as gastroparesis. As patients struggle with the life-altering effects of gastroparesis, or stomach paralysis, many are considering legal claims, seeking compensation and accountability from

Wegovy Gastroparesis Lawsuits: Patients Seek Compensation for Stomach Paralysis Injuries Read More »

Ozempic Lawsuit: Iowa Man Seeks Justice for Devastating Health Problems

An Iowa man has taken legal action against the manufacturers of Ozempic, a widely prescribed diabetes drug. In a product liability lawsuit filed last week in the U.S. District Court for the Northern District of Iowa, plaintiff Shawn Derrick alleges that Novo Nordisk and its subsidiaries failed to provide adequate warnings about the health risks

Ozempic Lawsuit: Iowa Man Seeks Justice for Devastating Health Problems Read More »

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate?

In recent years, millions of Americans have turned to medications like Ozempic, Wegovy, and Mounjaro, which belong to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RA), for weight loss and diabetes management. These drugs have been aggressively promoted by their manufacturers as safe and effective. However, a growing number of former

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate? Read More »

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial

More than five years after the initial valsartan recalls, the U.S. District Judge overseeing the valsartan litigation has greenlit the first trial against manufacturers and distributors of the tainted generic blood pressure drug. Over 1,200 valsartan lawsuits have been filed, with individuals alleging that changes to the manufacturing process resulted in the distribution of valsartan

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial Read More »

Zantac Cancer Lawsuit: Settlement Reached in 4,000 Claims Involving Recalled Heartburn Drug

Sanofi, the pharmaceutical company behind Zantac (ranitidine), has recently announced a significant settlement agreement to resolve approximately 4,000 cancer lawsuits filed in state courts across the United States. Although this settlement marks a step towards resolution, Sanofi still faces tens of thousands of pending claims related to the recalled heartburn drug, the majority of them

Zantac Cancer Lawsuit: Settlement Reached in 4,000 Claims Involving Recalled Heartburn Drug Read More »

Scroll to Top